MedPath

Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits

Not Applicable
Active, not recruiting
Conditions
Anxiety
Cognitive Deficit
Interventions
Device: Cranial Electrotherapy Stimulation
Device: Sham Cranial Electrotherapy Stimulation
Registration Number
NCT04961112
Lead Sponsor
Tufts University
Brief Summary

This study investigates the potential of cranial electrotherapy stimulation to mitigate anxiety induced cognitive deficits

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
124
Inclusion Criteria
  • Between 18-28 years old
Read More
Exclusion Criteria
  • History of diagnosis with a neurological or psychiatric disorder.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Experimental - No Induced AnxietyCranial Electrotherapy StimulationParticipants will be administered a shock procedure in which they are exposed to safe electrical shock that will be gradually increase from (1) 30 milliseconds to (4) 80 milliseconds to an individual threshold that is uncomfortable but not painful. After this procedure, the shock belt will be turned off. Participants will be told they will not receive additional shocks during cognitive assessments. Participants will be administered cranial electrotherapy stimulation with a frequency of .5 Hz and a current of 100 microamps during 30 minutes of cognitive assessments of task switching, inhibition (stroop), working memory (n-back), and processing speed (simple reaction time).
Experimental - Induced AnxietyCranial Electrotherapy StimulationParticipants will be administered a shock procedure in which they are exposed to safe electrical shock that will be gradually increase from (1) 30 milliseconds to (4) 80 milliseconds to an individual threshold that is uncomfortable but not painful. Participants will be told they may receive additional shocks for poor performance during cognitive assessments. Participants will be administered cranial electrotherapy stimulation with a frequency of .5 Hz and a current of 100 microamps during 30 minutes of cognitive assessments of task switching, inhibition (stroop), working memory (n-back), and processing speed (simple reaction time).
Sham - Induced AnxietySham Cranial Electrotherapy StimulationParticipants will be administered a shock procedure in which they are exposed to safe electrical shock that will be gradually increase from (1) 30 milliseconds to (4) 80 milliseconds to an individual threshold that is uncomfortable but not painful. Participants will be told they may receive additional shocks for poor performance during cognitive assessments. Participants will be administered sham cranial electrotherapy stimulation with no current during 30 minutes of cognitive assessments of task switching, inhibition (stroop), working memory (n-back), and processing speed (simple reaction time).
Sham - No Induced AnxietySham Cranial Electrotherapy StimulationParticipants will be administered a shock procedure in which they are exposed to safe electrical shock that will be gradually increase from (1) 30 milliseconds to (4) 80 milliseconds to an individual threshold that is uncomfortable but not painful. After this procedure, the shock belt will be turned off. Participants will be told they will not receive additional shocks during cognitive assessments. Participants will be administered sham cranial electrotherapy stimulation with no current during 30 minutes of cognitive assessments of task switching, inhibition (stroop), working memory (n-back), and processing speed (simple reaction time).
Primary Outcome Measures
NameTimeMethod
Processing speed (Simple reaction time task)68 weeks

Mean reaction time

Task switching68 weeks

Switch cost (mean switch reaction time- mean stay reaction time)

Working memory (N-back)68 weeks

2-back condition mean accuracy

Inhibition (Stroop)68 weeks

Stroop interference cost (mean incongruent reaction time- mean congruent reaction time)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tufts University

🇺🇸

Medford, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath